In this issue:
ESGE guideline: ERCP-related adverse events
Genomic diagnosis and care co-ordination for monogenic IBD
Vedolizumab, adalimumab, and methotrexate combination therapy in CD
U-ACHIEVE Maintenance study results
Preventing penetrating complications in patients with CD
Evaluating and managing belching, abdominal bloating, and distention
60-day prescriptions of PBS medicines
CWG draft findings report
Patients who revert to infliximab after biosimilar more likely to quit treatment
Mixed results for the use of AI during colonoscopies
COVID-19 resources
Conferences, workshops, and CPD
Please login below to download this issue (PDF)